Status:

COMPLETED

Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients

Lead Sponsor:

Cairo University

Conditions:

Neurodermatitis

Eligibility:

All Genders

55-75 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.

Detailed Description

Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chroni...

Eligibility Criteria

Inclusion

  • Age range between 55:75 years.
  • Male and female patients will participate in the study.
  • All patients have neurodermatitis.
  • All patients will be received the same approach of medication and nursing care.
  • All patients enrolled in the study will have their informed consent.

Exclusion

  • Patients diagnosed with cancer.
  • Pregnant woman.
  • active infection.
  • Patients with any systemic diseases that may interfere with the objectives of the study.
  • Cardiac pacemakers or other implantable devices.
  • Current anticoagulation use.
  • Any other cause of itching

Key Trial Info

Start Date :

December 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 25 2025

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT07206680

Start Date

December 15 2024

End Date

October 25 2025

Last Update

December 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Suez Canal University Hospital

Ismailia, Egypt

Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients | DecenTrialz